Next Article in Journal
Diffusion-Weighted MRI in Patients with Testicular Tumors—Intra- and Interobserver Variability
Previous Article in Journal
Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
Previous Article in Special Issue
Present and Emerging Biomarkers in Immunotherapy for Metastatic Non-Small Cell Lung Cancer: A Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Immunotherapy in Thoracic Malignancies: New Treatment and New Hope

BC Cancer, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada
Curr. Oncol. 2022, 29(2), 834-836; https://doi.org/10.3390/curroncol29020070
Submission received: 21 January 2022 / Revised: 21 January 2022 / Accepted: 29 January 2022 / Published: 2 February 2022
(This article belongs to the Special Issue Current State of Immunotherapy for Lung Cancer)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Over these last two pandemic years, we have all experienced profound changes in how we practice, how we work, and how we live [...]

Share and Cite

MDPI and ACS Style

Melosky, B. Immunotherapy in Thoracic Malignancies: New Treatment and New Hope. Curr. Oncol. 2022, 29, 834-836. https://doi.org/10.3390/curroncol29020070

AMA Style

Melosky B. Immunotherapy in Thoracic Malignancies: New Treatment and New Hope. Current Oncology. 2022; 29(2):834-836. https://doi.org/10.3390/curroncol29020070

Chicago/Turabian Style

Melosky, Barbara. 2022. "Immunotherapy in Thoracic Malignancies: New Treatment and New Hope" Current Oncology 29, no. 2: 834-836. https://doi.org/10.3390/curroncol29020070

APA Style

Melosky, B. (2022). Immunotherapy in Thoracic Malignancies: New Treatment and New Hope. Current Oncology, 29(2), 834-836. https://doi.org/10.3390/curroncol29020070

Article Metrics

Back to TopTop